Commissioning: Action Plan Report published
Monday, 05 September 2016 13:28
Further to the series of commissioning workshops the BSG ran in Birmingham, Newmarket, Manchester and London in May, please follow the link below to the final feedback Action Plan Report 'Achieving a Winning Business Case to Improve Outcomes in Gastroenterology & Hepatology Services'.
Those who also attended our Satellite Symposium on Thursday 23rd June at the BSG Annual Conference will know this Action Plan contains 'Ten Top Tips for Success' on the first page of the Report and in Appendix 1, Page 11 a 'Business Case Check List'. Appendix 2 on Pages 12 - 16 has two very useful Business Case Examples.
- Download full report [ 1.5 MB ]
UK National Screening Committee (UK NSC)
Friday, 02 September 2016 09:21
Stakeholder Conference 2016
Following the success of last year's inaugural event, this year's conference will be in London on Wednesday 14 December. As well as highlighting recent work of the UK NSC it will also mark the 20th anniversary since the committee was formed.
Confirmed speakers include:
- Sir Muir Gray, the UK NSC's first Programme Director
- Dr Angela Raffle, co-author of "Screening: Evidence and Practice"
- Prof Bob Steele, new Chair of the UK NSC
- Dr Anne Mackie, PHE Screening Director
IBD Registry Update: September 2016
Thursday, 01 September 2016 10:05
Local value of patient data - the Dorset experience
With the launch of the IBD Registry web tool last month, we're all set for every IBD team in the UK to join in, and to start to benefit from collecting useful local data to help deliver better patient care and support service development. Here Pearl Avery describes the approach she took to entering data on the PMS, involving patients in the process and the value of the information collected in the first ten months. This included being able to achieve CCG funding for the helpline for the first time in 20 years.
- Download full summary [ 168 kb ]
IBD Registry web tool launched
Thursday, 28 July 2016 08:23
Transition focus on biologics
To deliver local value to teams and patients, the steering group has proposed reporting on a set of 6 key performance indicators on biologics in 2016-17, with the aim of building a UK-wide register of all people receiving biological therapies for IBD by the end of 2017. The combined UK data will become a unique resource for real-world clinical effectiveness and health economic studies in IBD care.
- Download full update [ 43 kb ]
Page 5 of 11